Although granzyme B is selective on conserved amino acid sequences of its substrates, its cytotoxicity is non-specific to tumor cells, suggesting that granzyme B in active form, especially the one released to extracellular space, might harm both parties of the immune responses within the tumor microenvironment (TME) (5). The gene discussed is GZMB; the disease is neoplasm.